Imbruvica Replaces Chemo, Darzalex Boosts Standard Of Care In Front-Line CLL, Myeloma

 
• By Mandy Jackson
Tait Shanafelt AT American Society of Hematology
Tait Shanafelt of the Stanford University School of Medicine • Source: Courtesy of ASH

More from Clinical Trials

More from R&D